Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald W Northfelt

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
Investigational New Drugs|April 18, 2014
Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumorsBrian A Costello, Mitesh J Borad, Yingwei Qi, et al.
Plastic Surgery (Oakville, Ont.)|June 30, 2020
Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Current Understanding and Recommendations for ManagementTessa L St Cyr, Barbara A Pockaj, Donald W Northfelt, et al.
Cancer|December 17, 2019
Causes of death after breast cancer diagnosis: A US population-based analysisAhmed M Afifi, Anas M Saad, Muneer J Al-Husseini, et al.
Journal of Pain and Symptom Management|May 15, 2002
Dose conversion and titration with a novel, once-daily, OROS osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant painMark Palangio, Donald W Northfelt, Russell K Portenoy, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 6, 2024
Patient and nursing staff perspectives on automated scalp cooling (ASC) for chemotherapy-induced alopecia in breast cancerBenjamin E Ueberroth, Heidi E Kosiorek, Nellie N Nafissi, et al.
AJR. American Journal of Roentgenology|October 25, 2017
The Future of Contrast-Enhanced MammographyMatthew F Covington, Victor J Pizzitola, Roxanne Lorans, et al.
Annals of Surgical Oncology|March 9, 2018
Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic TherapyBhavika K Patel, Talal Hilal, Matthew Covington, et al.
International Journal of Clinical Oncology|October 12, 2012
Phase I trial of UNBS5162, a novel naphthalimide in patients with advanced solid tumors or lymphomaDaruka Mahadevan, Donald W Northfelt, Pavani Chalasani, et al.
American Journal of Clinical Oncology|August 8, 2012
A Phase II trial of docetaxel and carboplatin administered every 2 weeks as preoperative therapy for stage II or III breast cancer: NCCTG study N0338Vivek Roy, Barbara A Pockaj, Jacob B Allred, et al.
JAMA Oncology|July 29, 2018
Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical TrialJoseph Sparano, Anne O'Neill, Katherine Alpaugh, et al.
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
Investigational New Drugs|April 18, 2014
Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumorsBrian A Costello, Mitesh J Borad, Yingwei Qi, et al.
Plastic Surgery (Oakville, Ont.)|June 30, 2020
Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Current Understanding and Recommendations for ManagementTessa L St Cyr, Barbara A Pockaj, Donald W Northfelt, et al.
Cancer|December 17, 2019
Causes of death after breast cancer diagnosis: A US population-based analysisAhmed M Afifi, Anas M Saad, Muneer J Al-Husseini, et al.
Journal of Pain and Symptom Management|May 15, 2002
Dose conversion and titration with a novel, once-daily, OROS osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant painMark Palangio, Donald W Northfelt, Russell K Portenoy, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 6, 2024
Patient and nursing staff perspectives on automated scalp cooling (ASC) for chemotherapy-induced alopecia in breast cancerBenjamin E Ueberroth, Heidi E Kosiorek, Nellie N Nafissi, et al.
AJR. American Journal of Roentgenology|October 25, 2017
The Future of Contrast-Enhanced MammographyMatthew F Covington, Victor J Pizzitola, Roxanne Lorans, et al.
Annals of Surgical Oncology|March 9, 2018
Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic TherapyBhavika K Patel, Talal Hilal, Matthew Covington, et al.
International Journal of Clinical Oncology|October 12, 2012
Phase I trial of UNBS5162, a novel naphthalimide in patients with advanced solid tumors or lymphomaDaruka Mahadevan, Donald W Northfelt, Pavani Chalasani, et al.
American Journal of Clinical Oncology|August 8, 2012
A Phase II trial of docetaxel and carboplatin administered every 2 weeks as preoperative therapy for stage II or III breast cancer: NCCTG study N0338Vivek Roy, Barbara A Pockaj, Jacob B Allred, et al.
JAMA Oncology|July 29, 2018
Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical TrialJoseph Sparano, Anne O'Neill, Katherine Alpaugh, et al.
Pageof 11